CARDINAL HEALTH INC shareholders Q3 2023

CARDINAL HEALTH INC's ticker is CAH and the CUSIP is 14149Y108. A total of 935 filers reported holding CARDINAL HEALTH INC in Q3 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

CARDINAL HEALTH INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tidal Investments LLC 9,369$812,4210.02%
Foster Group, Inc. 4,498$390,5160.02%
WESTFIELD CAPITAL MANAGEMENT CO LP 41,183$3,575,5080.02%
Walleye Trading LLC 103,400$8,977,1880.02%
THRIVENT FINANCIAL FOR LUTHERANS 117,418$10,1970.02%
TOMPKINS FINANCIAL CORP 1,790$155,4080.02%
Meridian Wealth Management, LLC 4,541$394,2500.02%
GIRARD PARTNERS LTD. 2,403$208,6280.02%
Diversified Trust Co 6,919$600,7070.02%
KESTRA PRIVATE WEALTH SERVICES, LLC 8,301$720,6930.02%
Dorsey & Whitney Trust CO LLC 3,063$265,9300.02%
CANTOR FITZGERALD, L. P. 9,860$856,0450.02%
Headlands Technologies LLC 539$46,7960.02%
MILLENNIUM MANAGEMENT LLC 535,900$46,526,8380.02%
Vontobel Holding Ltd. 48,362$4,198,7880.02%
Ensign Peak Advisors, Inc 116,002$10,071,2950.02%
Baird Financial Group, Inc. 91,814$7,971,3210.02%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 1,564$135,7860.02%
ENVESTNET ASSET MANAGEMENT INC 558,756$48,511,2280.02%
ASSETMARK, INC 61,974$5,380,5830.02%
About CARDINAL HEALTH INC

Cardinal Health Inc. is a leading healthcare services and products company that provides pharmaceuticals, medical products, and services to hospitals, pharmacies, and healthcare providers. The company operates in two segments: Pharmaceutical and Medical.

The Pharmaceutical segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals, over-the-counter healthcare products, and consumer health products. The Medical segment distributes medical, surgical, and laboratory products to hospitals, surgery centers, and physician offices.

Cardinal Health has a strong presence in the United States and operates in over 60 countries worldwide. The company has a market capitalization of over $15 billion and employs over 50,000 people.

In recent years, Cardinal Health has focused on expanding its product offerings and services to meet the changing needs of the healthcare industry. The company has made several strategic acquisitions, including the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses.

Cardinal Health has also been recognized for its commitment to sustainability and corporate responsibility. The company has been named to the Dow Jones Sustainability Index for the past 10 years and has received numerous awards for its environmental and social initiatives.

Overall, Cardinal Health is a well-established and respected player in the healthcare industry, with a strong track record of growth and innovation. As the healthcare landscape continues to evolve, Cardinal Health is well-positioned to continue delivering value to its customers and shareholders.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists CARDINAL HEALTH INC's shareholders in Q3 2023. To view CARDINAL HEALTH INC's shareholder history, click here.